Adolescents Seeking COVID Vaccination (Teen COVID Vax)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

454 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-09-26

Study Completion Date

2023-07-12

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Background:

Information is limited on the experience of children aged 15 to 17 who have or have not been vaccinated against COVID-19. Research has assessed attitudes toward COVID-19 vaccination among adults and parents of teenagers. Few surveys have explored attitudes among teens themselves.

Objective:

This anonymous cross-sectional survey of a national sample US teens to find out about their experiences and attitudes on getting vaccinated for COVID-19. This study will be conducted in collaboration with a national firm (Qualtrics) responsible for the recruitment and data collection.

Eligibility:

People aged 15 to 17 years. Participants will come from urban, suburban, and rural areas in the United States. Factors such as race and gender will match US averages.

Participants will only include subjects recruited by Qualtrics from their national panel of available respondents, who have agreed to be contacted by Qualtrics with opportunities to participate in surveys.

Design:

Participants will be contacted by email. The email will include a link to the survey. The emails will be sent only to people who agreed to be contacted about taking surveys.

Participants will complete the survey online. It should take only 10 minutes.

Questions will include the following:

Have participants been vaccinated against COVID-19? Are they in the process of getting vaccinated?

Do they want to be vaccinated?

Have they had trouble getting vaccinated? If so, what kind of barriers did they face?

What reasons have they considered for and against getting vaccinated?

What have their personal experiences been with COVID-19?

What is their primary source of information about COVID-19?

Other questions will ask about:

Household size.

Employment of people in the household.

How many people in the house have been vaccinated.

The primary language spoken at home.

The natural history survey will be anonymous. Participants will not be asked to give their names....

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Adolescent Vaccination in Pharmacies

NCT01960088

Evaluating Attitudes Toward HPV Vaccinations in Pharmacies Evaluating the Provision of HPV Vaccines in a Pharmacy

COMPLETED

An Evaluation of Tailored Messages to Address Parental Questions About HPV Vaccination

NCT03628885

Human Papilloma Virus Vaccines Attitude to Health

COMPLETED NA

HPV Vaccination Health-promotion Programme on Vaccine Acceptance and Uptake Among Female Adolescents

NCT04438291

HPV Infection Health Behavior Health Attitude

COMPLETED NA

Clinical Trial of Recombinant COVID-19 Vaccine (Sf9 Cells) in Children and Adolescents

NCT05013983

COVID-19

WITHDRAWN PHASE1/PHASE2

Perception, Awareness, and Acceptance of Human Papillomavirus Disease and Vaccine Among Parents of Boys Aged 9 to 18 Years

NCT01197079

Human Papillomavirus (HPV)

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The project will survey a representative sample of US adolescents age 15-17 and English speaking. This age group has been selected because they are likely to currently be High School students and are eligible for vaccination under the current Emergency Use Authorization (EUA) for and approval of the Pfizer-BioNTech COVID vaccine. The Pfizer-BioNTech vaccine received an EUA for those 16 and over in December of 2020, and was approved for this age group in August of 2021. Pfizer received an EUA for those 12 to 15 in May of 2021.

We are targeting a total of 460 responses which will give us a sufficient sample size to have a target power of 0.901 and 0.05 alpha to test our primary hypothesis that adolescents in rural settings are more likely to have encountered barriers in their pursuit of COVID vaccination. The respondents will be a convenience sample recruited from the Qualtrics panel, with demographic characteristic quotas (race/ethnicity, gender etc..) to approximate the most recent US census. The inclusion criteria are: age 15-17, and living in urban, suburban or rural community

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ease Of Access To Covid Vaccine

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

15-17 year olds from US general population

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age 15-17, and
* living in urban, suburban or rural community
* Participants will only include subjects recruited by Qualtrics from their national panel of available respondents, who have agreed to be contacted by Qualtrics with opportunities to participate in surveys.

Minimum Eligible Age

15 Years

Maximum Eligible Age

17 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes